prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - AP Surgical Pathology: Additional info d. CLINICAL HISTORY: Rule out malignancy of left breast. Palpable left breast mass within large. axillary node. If invasive carcinoma, please obtain ER, PR, EGFR, HER2/Neu by. immunohistochemistry; for all 2+ IHC results please do FISH analysis. GROSS EXAMINATION: A. "USNCB left breast, number of cores 4, 11:00 site 1", received in formalin. is a 1 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is. submitted entirely in a mesh bag in block A1. B. "USNCB left breast, number of cores 4, axilla site 2", received in formalin. is a 0.9 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is. submitted entirely in a mesh bag in block B1. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. "LEFT BREAST, 11:00, SITE ONE" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY). INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL, WITH LOBULAR FEATURES. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: SOLID. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN A SEPARATE REPORT FROM THE IMAGE CYTOMETRY. LAB. B. "LEFT BREAST, AXILLA, SITE TWO" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY) : LYMPH NODE WITH METASTATIC DUCTAL ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). - - ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).

expanded version (tokens=974) : 
 The breast pathology report reveals the following information:

1. Histological classification: 
    a. Invasive Adenocarcinoma of the breast; 
    b. Ductal, with lobular features
    c. Solid In-situ carcinoma

2. Histological grade:
    a. Nottingham combined histologic grade: 3 of 3;
    b. Tubule formation score: 3;
    c. Nuclear pleomorphism score: 3;
    d. Mitotic rate score: 2;
    e. Nuclear grade of in-situ carcinoma: 3 of 3

3. Receptor status: Pending

4. Lymphovascular invasion: Not mentioned

5. Tumor infiltrating lymphocytes: Not mentioned

6. Calcification: Not mentioned

7. IHC and any other ancillary testing results: 
    a. ER, PR, Her2/Neu, and EGFR analysis: Pending
    b. Supplementary tests: results pending

In summary, the breast pathology report indicates the presence of invasive adenocarcinoma, ductal, with lobular features, and solid in-situ carcinoma. It also highlights the Nottingham combined histologic grade (3 of 3), tubule formation, nuclear pleomorphism, and mitotic rate scores, and nuclear grade of in-situ carcinoma. However, the receptor status, lymphovascular invasion, tumor infiltrating lymphocytes, and calcification are not

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1105) : 
 The left breast biopsy revealed the presence of invasive ductal carcinoma with lobular features and solid in-situ carcinoma. The tumor is of high histological grade (Nottingham combined histological grade 3 of 3) with a mitotic rate score of 2. The receptor status (ER, PR, Her2/Neu) and lymphovascular invasion were not mentioned. Supplementary test results are pending.

